Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 December 2022 | Story Jóhann Thormählen | Photo Asem Engage/Hannes Naude
Sello Diphoko
Sello Diphoko was the Man of the Match in his last Varsity Football game for the University of the Free State.

Come to Kovsies and go places!’ is a motto used at Kovsie Soccer, and Sello Diphoko’s journey exemplifies this. The UFS striker’s humble beginnings and rise to the United States of America is one that inspires.

Two years ago, he didn’t even play club soccer, but he was scouted by the UFS and given an opportunity that changed his life. Diphoko recently received a scholarship at the University of the Incarnate Word in San Antonio, Texas.

Playing street football

It all started in February 2020 when he was invited to UFS soccer trials by a friend, Lwanda Ciko, who is also from Soutpan outside Bloemfontein.

“Before I came here, I was playing street football,” says Diphoko. “I have never played in a professional or semi-professional league; I came straight from the streets.” And it took Tebogo Motsamai, UFS head coach, only 25 minutes to identify his talent.

According to Godfrey Tenoff, Diphoko was attending Motheo College and gained access to the UFS through the University Preparation Programme.

“We are totally proud of Sello,” says the Head of Soccer at KovsieSport. “He is a perfect example of preparation meeting opportunity and that opportunity creating a great opportunity.”

In 2021, his Varsity Football debut year, Diphoko was crowned Player of the Tournament and received the Golden Boot award. A year later, he can barely believe it happened. “Yoh. It is huge! But it was all about the teamwork and support I got from my teammates.”

Changing students’ lives

A few South African teams wanted to sign him up, but his education was non-negotiable. A move abroad was eventually the best for Diphoko’s career – on and off the pitch.

Tenoff says the “talent identification pathway has now been paved”. The UFS understands the processes, what it is capable of, and it shows the university can equip and prepare students for international opportunities.

“It says that KovsieSport is serious about changing the lives of the students that come into our programme. It tells me that we have the will to make a way for our students. This is a small part of what is to come in KovsieSport, Kovsie Soccer, and the UFS.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept